1 week Ago By ICICI Securities
Navin Fluorine’s Ebitda to grow 63.6% YoY aided by stronger showing across segments. Gujarat Fluorochemicals’ Ebitda may grow 42.
8% YoY with higher volumes in fluoropolymers. SRF’s Ebitda may rise 37.3% YoY due to strong growth in specialty chemicals/ref-gas; packaging films Ebit to help given the spurt in spreads.
EPL’s Ebitda (+14.5% YoY) could benefit from lower input prices, steady volume growth and Ebit margin expansion in the Americas and Europe.NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies.
These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.ICICI Securities ReportWe estimate our specialty chemicals coverage universe’s revenue to grow 14% YoY/11.5% QoQ in Q4 FY25E on a low base alongside a gradual demand recovery.
Ebitda too, on a low base, should grow 33% YoY/23.4% QoQ with SRF, Navin Fluorine, Gujarat Fluorochemical, Archean and BlueJet likely outperforming. Company-wise highlights:SRF’s Ebitda may rise 37.
3% YoY due to strong growth in specialty chemicals/ref-gas; packaging films Ebit to help given the spurt in spreads. Navin Fluorine’s Ebitda to grow 63.6% YoY aided by stronger showing across segments.
Gujarat Fluorochemicals’ Ebitda may grow 42.8% YoY with higher volumes in fluoropolymers. Clean Science’s Ebitda may grow 7.
8% YoY on higher volume off-take; margin may drop QoQ due to lower margins for HALS, as expected. EPL’s Ebitda (+14.5% YoY) could benefit from lower input prices, steady volume growth and Ebit margin expansion in the Americas and Europe.
Tatva Chintan’s Ebitda may decline 49.6% YoY due to subdued revenue. Galaxy Surfactants’ volumes to grow at 5.
4% YoY; Ebitda/kg may be stable QoQ, but likely fall short of guidance.Chemplast’s Ebitda to remain subdued due to depressed spreads in PVC business. PCBL’s volumes growth to recover with 6% YoY growth; but gross profit/kg to dip 6.
8% YoY on high base. Aquapharm’s Ebit margin trend to be subdued.Sudarshan’s revenue trajectory to improve; operating leverage should aid better margins.
Rossari’s Ebitda to be flattish YoY on pressure on margins. Archean’s Ebitda (43.7% YoY) to improve significantly with volume recovery for salt and bromine.
Atul’s Ebitda will likely show healthy growth of 75.5% YoY aided by improvement in spreads and higher volume off take. BlueJet’s Ebitda (+147% YoY) to benefit from sales growth resuming in PI & API segment.
Himadri’s Ebitda growth (+32.6% YoY) to accelerate as low base catch-up, volume growth remains healthy, and higher gross profit/kg YoY.Click on the attachment to read the full report:Metals Q4 Results Preview: Tariffs To Test Sector’s Mettle, Says ICICI Securities, APL Apollo Among Top PicksDISCLAIMERThis report is authored by an external party.
NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs.
The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.Users have no license to copy, modify, or distribute the content without permission of the Original Owner..
Read more on Research Reports by NDTV Profit..
